DK2003202T3 - G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf - Google Patents

G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf

Info

Publication number
DK2003202T3
DK2003202T3 DK08165936.9T DK08165936T DK2003202T3 DK 2003202 T3 DK2003202 T3 DK 2003202T3 DK 08165936 T DK08165936 T DK 08165936T DK 2003202 T3 DK2003202 T3 DK 2003202T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
phor
coupled receptor
regulated
applications
Prior art date
Application number
DK08165936.9T
Other languages
English (en)
Inventor
Arthur B Raitano
Daniel E H Afar
Aya Jakobovits
Mary Faris
Rene S Hubert
Steve C Mitchell
Douglas C Saffran
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of DK2003202T3 publication Critical patent/DK2003202T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK08165936.9T 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf DK2003202T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15790299P 1999-10-05 1999-10-05
EP00967335A EP1220913B1 (en) 1999-10-05 2000-10-05 G protein-coupled receptor up-regulated in prostate cancer and uses thereof

Publications (1)

Publication Number Publication Date
DK2003202T3 true DK2003202T3 (da) 2012-01-16

Family

ID=22565799

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf
DK08165936.9T DK2003202T3 (da) 1999-10-05 2000-10-05 G-protein-koblet receptor opreguleret i prostatacancer og anvendelser deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK00967335T DK1220913T3 (da) 1999-10-05 2000-10-05 G-protein-koblet-receptor opreguleret i prostatacancer og anvendelser deraf

Country Status (13)

Country Link
EP (2) EP2003202B1 (da)
JP (2) JP4272376B2 (da)
AT (2) ATE524549T1 (da)
AU (2) AU779685B2 (da)
CA (1) CA2385032C (da)
CY (2) CY1110059T1 (da)
DE (1) DE60041073D1 (da)
DK (2) DK1220913T3 (da)
ES (2) ES2371212T3 (da)
HK (1) HK1048494B (da)
IL (1) IL147952A0 (da)
PT (2) PT1220913E (da)
WO (1) WO2001025434A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790631B1 (en) 1999-10-05 2004-09-14 Agensys, Inc. G protein-coupled receptor up-regulated in prostate cancer and uses thereof
US7361338B2 (en) 1999-10-05 2008-04-22 Agensys, Inc. Methods to inhibit growth of prostate cancer cells
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
CA2447564A1 (en) * 2001-05-15 2002-11-21 Agensys, Inc. Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer
EP1864131B1 (en) * 2005-03-03 2011-09-28 ChemCom S.A. Natural ligand of g protein coupled receptor rcc356 and uses thereof
JPWO2007119515A1 (ja) * 2006-03-28 2009-08-27 昇志 佐藤 新規腫瘍抗原ペプチド
JP2012196211A (ja) * 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
GB8724885D0 (en) 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US4975287A (en) 1989-09-01 1990-12-04 Wm. Wrigley Jr. Company Gum composition containing protein macrocolloids
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
WO1992000311A1 (en) 1990-06-27 1992-01-09 Princeton University Probes for detecting mutant p53
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
EP0773952B1 (en) 1994-07-20 2003-11-12 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5919652A (en) 1994-11-09 1999-07-06 The Regents Of The University Of California Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
NZ502795A (en) 1995-04-11 2001-09-28 Gen Hospital Corp Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
EP0832122A4 (en) 1995-06-05 1999-08-25 Human Genome Sciences Inc HUMAN G-PROTEIN RECEPTOR HPRAJ70
WO1997041255A1 (en) 1996-04-26 1997-11-06 Massachusetts Institute Of Technology Three-hybrid screening assay
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
EP0953039B1 (en) 1996-10-15 2007-08-29 The Regents Of The University Of California Animal models of human prostate cancer progression
US5846722A (en) 1996-10-16 1998-12-08 Terrapin Technologies, Inc. System to detect small molecule/peptide interaction
ATE549918T1 (de) 1996-12-03 2012-04-15 Amgen Fremont Inc Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
CA2296287A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in prostate
JP2002520054A (ja) * 1998-07-14 2002-07-09 コリクサ コーポレイション 前立腺癌の治療及び診断のための組成物及び方法
CA2345045A1 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
CY1110059T1 (el) 2015-01-14
JP4875671B2 (ja) 2012-02-15
ATE524549T1 (de) 2011-09-15
CA2385032A1 (en) 2001-04-12
PT1220913E (pt) 2009-02-16
AU2005201916A1 (en) 2005-06-02
AU779685B2 (en) 2005-02-03
AU2005201916B2 (en) 2008-06-19
IL147952A0 (en) 2002-08-14
PT2003202E (pt) 2012-01-02
JP4272376B2 (ja) 2009-06-03
AU7755300A (en) 2001-05-10
CY1112202T1 (el) 2015-12-09
EP2003202A2 (en) 2008-12-17
DK1220913T3 (da) 2009-03-16
ATE417104T1 (de) 2008-12-15
WO2001025434A1 (en) 2001-04-12
EP2003202A3 (en) 2009-10-21
CA2385032C (en) 2013-12-10
DE60041073D1 (de) 2009-01-22
EP1220913B1 (en) 2008-12-10
ES2371212T3 (es) 2011-12-28
JP2003511029A (ja) 2003-03-25
JP2009050256A (ja) 2009-03-12
EP2003202B1 (en) 2011-09-14
ES2316387T3 (es) 2009-04-16
AU2005201916A2 (en) 2005-08-25
HK1048494B (en) 2009-06-12
EP1220913A1 (en) 2002-07-10
HK1048494A1 (en) 2003-04-04

Similar Documents

Publication Publication Date Title
ATE486938T1 (de) C-typ-lektin-transmembran-antigen, das in menschlichem prostatakrebs exprimiert wird, und verwendungen dieses antigens
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
ES2202432T3 (es) Factor de crecimiento endotelial vascular b.
EP1488007A4 (en) PERFORMANCE OF GENE EXPRESSION IN BIOPTIC TUMOR TISSUE
WO1998010069A3 (en) E25a protein, methods for production and use thereof
WO1999064576A3 (en) Human genes differentially expressed in colon cancer
SG145559A1 (en) Genes and polypeptides relating to human colon cancers
MXPA02011142A (es) Plataforma de nanodispositivo multifuncional.
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
CY1112202T1 (el) Υποδοχεας συζευγμενος προς g πρωτεϊνη θετικως ρυθμισμενος σε καρκινο προστατη και χρησεις αυτου
HUP9901908A2 (hu) p16 Expressziós konstrukciók és alkalmazásuk rákterápiában
ATE412412T1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1 -pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata-oder gebahrmutterkrebs
HUP0300054A1 (hu) Daganatspecifikus állati fehérjék
Trieb et al. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
ATE364315T1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
ATE313647T1 (de) Dickdarm spezifische gene und proteine
WO2003023060A3 (de) Verfahren und kit zur diagnostik oder behandlungskontrolle von brustkrebs
IL143988A0 (en) Compositions and methods for intraductal gene therapy
WO2001090157A8 (en) 98p7c3: homeodomain protein highly expressed in various cancers
US6171818B1 (en) Protein having an anti-tumoral effect
WO2003025135A3 (en) Genes associated with malignant neoplasms
Hogen et al. EP008/# 378 Comparative genomic analysis of ovarian clear cell carcinoma patients with and without a second primary malignancy
ATE340256T1 (de) Säuger-krebszelle und menschliches protoonkogen tragender transgener säuger sowie kit zur krebsdiagnose mit dem protoonkogen
NZ502270A (en) Derivatives of mammalian secretory peptide-9 for treating cancer and may be used in conjunction with cytokines